Literature DB >> 11399721

Talc preparations used for pleurodesis vary markedly from one preparation to another.

J Ferrer1, M A Villarino, J M Tura, A Traveria, R W Light.   

Abstract

BACKGROUND: At the present time, talc is the one of the agents most commonly used for the production of a pleurodesis. However, there have been several recent reports of acute pneumonitis developing after the intrapleural administration of talc. The incidence of pneumonitis has varied markedly from center to center.
OBJECTIVE: To compare the physical characteristics of talc used for the production of pleurodesis in various localities.
DESIGN: Eight talc preparations (four from the United States, and one each from Brazil, France, Spain, and Taiwan) were analyzed for the distribution of the particle size and the type and amount of impurities. MEASUREMENTS: The physical characteristics of the talc specimens were determined using radiograph diffraction and scanning electron microscopy.
RESULTS: The mean and median particle size varied by more than a factor of three among the eight different talc preparations. In addition, the impurities of the different talc preparations were quite varied.
CONCLUSIONS: We conclude that there is marked variation in the physical characteristics of the talc preparations used intrapleurally for the production of a pleurodesis. We speculate that different incidences of acute pneumonitis at various centers after intrapleural administration of talc may be due to differences in the physical characteristics of the talc preparations used for pleurodesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11399721     DOI: 10.1378/chest.119.6.1901

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  BTS guidelines for the management of malignant pleural effusions.

Authors:  G Antunes; E Neville; J Duffy; N Ali
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.

Authors:  Carolyn M Dresler; Jemi Olak; James E Herndon; William G Richards; Ernest Scalzetti; Stewart B Fleishman; Kemp H Kernstine; Todd Demmy; David M Jablons; Leslie Kohman; Thomas M Daniel; George B Haasler; David J Sugarbaker
Journal:  Chest       Date:  2005-03       Impact factor: 9.410

3.  Persistent Inflammation in Pulmonary Granuloma 48 Years after Talcage Pleurodesis, Detected by FDG-PET/CT.

Authors:  J C Fanggiday; R W Rouse; S M Collard; M J de Haas; J M H de Klerk
Journal:  Case Rep Med       Date:  2012-11-06

Review 4.  Perineal talc use and ovarian cancer: a critical review.

Authors:  Joshua E Muscat; Michael S Huncharek
Journal:  Eur J Cancer Prev       Date:  2008-04       Impact factor: 2.497

Review 5.  Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology.

Authors:  Siyamek Neragi-Miandoab
Journal:  Support Care Cancer       Date:  2008-02-08       Impact factor: 3.603

6.  An update in the management of malignant pleural effusion.

Authors:  Dk Muduly; Svs Deo; Ts Subi; Aa Kallianpur; Nk Shukla
Journal:  Indian J Palliat Care       Date:  2011-05

7.  Interpretation of PET/CT findings in patients with advanced lung cancer who have undergone pleurodesis.

Authors:  Marcus Paulo Fernandes Amarante; Riad Naim Younes; Letícia Rigo; Marcelo Rocha de Sousa Cruz
Journal:  Ecancermedicalscience       Date:  2014-08-12

8.  Comparisons of doxycycline solution with talc slurry for chemical pleurodesis and risk factors for recurrence in South Korean patients with spontaneous pneumothorax.

Authors:  Eun Ha Park; Joo Hee Kim; Jeong Yee; Jee Eun Chung; Jong Mi Seong; Hyen Oh La; Hye Sun Gwak
Journal:  Eur J Hosp Pharm       Date:  2018-04-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.